Jose Antonio Gonzalez-Correa

Prof. Dr. Jose Antonio Gonzalez-Correa

University of Malaga, Málaga, Andalusia, Spain
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
JGJose Antonio Gonzalez-Correa
Jose Antonio Gonzalez-Correa
MNMaría Dolores Navas
María Dolores Navas
JLJuan Antonio Lopez-Villodres
Juan Antonio Lopez-Villodres
MTMariana Trujillo
Mariana Trujillo
JEJose Luis Espartero
Jose Luis Espartero
JCJose pedro de la cruz
Jose pedro de la cruz

6 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAlonso Montiel-Luque
Alonso Montiel-Luque
ANAntonio Jesús Núñez-Montenegro
Antonio Jesús Núñez-Montenegro
EMEsther Martín-Aurioles
Esther Martín-Aurioles
JCJose Carlos Canca-Sánchez
Jose Carlos Canca-Sánchez
MTMaria Carmen Toro-Toro
Maria Carmen Toro-Toro
OGon behalf of the Polipresact Research Group
on behalf of the Polipresact Research Group
In the current public health framework, the importance of medication as a determinant of citizens’ health has emerged as a factor warranting special attention. Most studies investigating the relationship between medication and quality of life do so from the perspective of adherence. However, other medication-related factors identified at home visits may be associated with health-related quality of life. Objective: To describe the relationship between medication-related factors and the health-related quality of life in patients older than 65 years who use multiple medications (polypharmacy). Design: Cross-sectional descriptive study. Setting: Primary care. Participants: Patients older than 65 years who use multiple medications (n = 375). Measurements: The main outcome measure was health-related quality of life according to the EuroQol-5D instrument. Sociodemographic, clinical and medication-related variables were recorded during home interviews. Mean age was 74.72 ± 5.59 years, and 65.5% of our participants were women. The global level of health-related quality of life according to the EQ-5D visual analog scale was 59.25 ± 20.92. Of the five EuroQol dimensions, anxiety/depression and pain were the most frequently reported, while mobility and self-care were the dimensions with the greatest impact on self-reported quality of life. Multivariate analysis indicated that functional independence was the factor most strongly associated (β = 14.27 p < 0.001) with better health-related quality of life, while illiteracy (β = −13.58 p < 0.001), depression (β = −10.13 p < 0.001), social risk (β = −7.23 p = 0.004) and using more than 10 medicines (β = −4.85 p = 0.009) were strongly associated with a poorer health-related quality of life. Factors inherent within the patient such as functional incapacity, cognitive impairment and social and emotional problems were the main constraints to quality of life in our study population. The number of medicines taken was negatively related with quality of life.

1 March 2004 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
JCJose pedro de la cruz
Jose pedro de la cruz
JGJose Antonio Gonzalez-Correa
Jose Antonio Gonzalez-Correa
AGAna Guerrero
Ana Guerrero
FCFelipe Sánchez De La Cuesta
Felipe Sánchez De La Cuesta

16 August 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
JGJose Antonio Gonzalez-Correa
Jose Antonio Gonzalez-Correa
MNMaría Dolores Navas
María Dolores Navas
JMJavier Muñoz-Marín
Javier Muñoz-Marín
MTMariana Trujillo
Mariana Trujillo
JUAN FERNANDEZ-BOLAÑOSJUAN FERNANDEZ-BOLAÑOS
JUAN FERNANDEZ-BOLAÑOS
JCJose pedro de la cruz
Jose pedro de la cruz

8 September 2008 in British Journal of Nutrition
Verified
Journal Article
Closed access
JGJose Antonio Gonzalez-Correa
Jose Antonio Gonzalez-Correa
JLJuan Antonio López-Villodres
Juan Antonio López-Villodres
RARocío Asensi
Rocío Asensi
JEJose Luis Espartero
Jose Luis Espartero
GRGuillermo Rodriguez-Gutierrez
Guillermo Rodriguez-Gutierrez
JCJose pedro de la cruz
Jose pedro de la cruz
Hydroxytyrosol acetate (HT-AC) is a polyphenol present in virgin olive oil (VOO) at a proportion similar to hydroxytyrosol (HT) (160–479 μmol/kg oil). The present study was designed to measure thein vitroplatelet antiaggregating activity of HT-AC in human whole blood, and compare this effect with that of HT and acetylsalicylic acid (ASA). The experiments were designed according to the standard procedure to investigate the activity of ASA. HT-AC and HT inhibited platelet aggregation induced by ADP, collagen or arachidonic acid in both whole blood and platelet-rich plasma (PRP). ASA and HT-AC had a greater effect in whole blood than in PRP when ADP or collagen was used as inducer. ASA and HT-AC had a greater effect in PRP+leucocytes than in PRP alone. All three compounds inhibited platelet thromboxane B2and leucocyte 6-keto-prostaglandin F1α(6-keto-PF1α) production. The thromboxane/6-keto-PGF1αinhibition ratio (as an indirect index of the prostanoid equilibrium) was 10·8 (se1) for HT-AC, 1·0 (se0·1) for HT and 3·3 (se0·2) for ASA. All three compounds stimulated nitric oxide production, although HT was a weaker effect. In our experiments only concentrations higher than 500 μm(HT) or 1 mm(HT-AC and ASA) inhibited 3-nitrotyrosine production. All three compounds inhibited the production of TNFα by leucocytes, with no significant differences between them. In quantitative terms HT-AC showed a greater antiplatelet aggregating activity than HT and a similar activity to that of ASA. This effect involved a decrease in platelet thromboxane synthesis and an increase in leucocyte nitric oxide production.

7 August 2007 in Lipids
Verified
Journal Article
Closed access
PDF file
JGJose Antonio Gonzalez-Correa
Jose Antonio Gonzalez-Correa
JMJ. Muñoz‐Marín
J. Muñoz‐Marín
MAM. M. Arrebola
M. M. Arrebola
AGA. Guerrero
A. Guerrero
FNF. Narbona
F. Narbona
JCJose pedro de la cruz
Jose pedro de la cruz